Cargando…
Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patients
Progesterone is used to treat uterine endometrial cancer in young patients wishing to preserve their fertility as well as in advanced or recurrent patients, but its response rate is limited. The antitumor effect of progesterone is mediated by progesterone receptor (PR) binding. Hence, loss of proges...
Autores principales: | Yoriki, Kaori, Mori, Taisuke, Aoyama, Kohei, Tarumi, Yosuke, Kataoka, Hisashi, Kokabu, Tetsuya, Kitawaki, Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206647/ https://www.ncbi.nlm.nih.gov/pubmed/35717540 http://dx.doi.org/10.1038/s41598-022-13842-6 |
Ejemplares similares
-
Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
por: Yoriki, Kaori, et al.
Publicado: (2019) -
Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature review
por: Kokabu, Tetsuya, et al.
Publicado: (2022) -
Successful resection of growing teratoma syndrome in the abdominal wall with reconstruction using tensor fascia lata muscle flap: A case report and literature review
por: Iwai, Miho, et al.
Publicado: (2023) -
Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer
por: Matsushima, Hiroshi, et al.
Publicado: (2016) -
Giant retroperitoneal dedifferentiated liposarcoma mimicking ovarian cancer: A case report
por: Tani, Akihiro, et al.
Publicado: (2022)